Phase II evaluation of gefitinib in patients with newly diagnosed grade 4 astrocytoma: Mayo/north central cancer treatment group study n0074
Joon H. Uhm, Karla V. Ballman, Wenting Wu, Caterina Giannini, J. C. Krauss, Jan C. Buckner, C. D. James, Bernd W. Scheithauer, Robert J. Behrens, Patrick J. Flynn, Paul L. Schaefer, Shaker R. Dakhill, Kurt A. Jaeckle
Dive into the research topics of 'Phase II evaluation of gefitinib in patients with newly diagnosed grade 4 astrocytoma: Mayo/north central cancer treatment group study n0074'. Together they form a unique fingerprint.